# Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

> **NCT06137040** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 100 (estimated)

## Conditions studied

- Asthma in Children
- Asthma Attack

## Interventions

- **DRUG:** Magnesium Sulfate within the first hour
- **OTHER:** No Magnesium sulfate within the first hour

## Key facts

- **NCT ID:** NCT06137040
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-30
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137040, "Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06137040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*